Mangrove Partners
- SEC CIK
- 0001535392
- Latest filing
- Aug 14, 2026
MREO holding history
Mereo BioPharma Group plc in every 13F filed by Mangrove Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MREO overviewAll 13F holders of MREOFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −7,790,580−100.0% | Sold out | Holders |
| Q3 2025 | 7,790,580 | $16.0M | 1.3% | −845,905−9.8% | Reduced | Holders |
| Q2 2025 | 8,636,485 | $23.4M | 2.5% | 00.0% | Unchanged | Holders |
| Q1 2025 | 8,636,485 | $19.4M | 2.2% | 00.0% | Unchanged | Holders |
| Q4 2024 | 8,636,485 | $30.2M | 3.6% | −93,235−1.1% | Reduced | Holders |
| Q3 2024 | 8,729,720 | $35.9M | 3.5% | −23,173−0.3% | Reduced | Holders |
| Q2 2024 | 8,752,893 | $31.5M | 2.8% | 00.0% | Unchanged | Holders |
| Q1 2024 | 8,752,893 | $28.9M | 2.5% | 00.0% | Unchanged | Holders |
| Q4 2023 | 8,752,893 | $20.2M | 1.8% | +3,221,346+58.2% | Added | Holders |
| Q3 2023 | 5,531,547 | $7.14M | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2023 | 5,531,547 | $7.30M | 0.7% | +5,531,547 | New | Holders |